Encouraged by the findings that overexpression of Klf15 in neonatal Mrps5cKO mice was sufficient to prevent the development of cardiac hypertrophy, we explored the potential for Klf15 in the treatment of cardiac defects in adult Mrps5 mutant mice. This evidence concerns the gene KLF15 and cardiac hypertrophy.